T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at DiagnosisFlorus C. de Jong, Tahlita C.M. Zuiverloon, Joost L. Boormans et al.|The Journal of Urology|2020Cited by 27
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCGFlorus C. de Jong, Tahlita C.M. Zuiverloon, Vebjørn Kvikstad et al.|World Journal of Urology|2025Cited by 8
A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with RadiotherapyFlorus C. de Jong, Joost L. Boormans, Iris G. Iflé et al.|European Urology Open Science|2024Cited by 5
Definitions of BCG-failure (EAU) vs BCG-unresponsive (FDA) in high-risk non-muscle invasive bladder cancer: A comparison of patient outcomeFlorus C. de Jong, Tahlita C.M. Zuiverloon, Joost L. Boormans et al.|European Urology Open Science|2020Cited by 2